At the beginning of July, a television campaign started for a new product in the USP Zdrowie portfolio – APAP intense, containing 500 mg of paracetamol and 200 mg of ibuprofen. Our new APAP intense is the most powerful pain medication in the APAP portfolio¹.

In the advertisement, we emphasize that APAP intense is a product that relieves really intense pain (e.g., back pain), has a dual action: for pain and inflammation, and does not cause addiction like some strong medications. In the spot, we also highlight the duration of APAP intense’s effect – over 8 hours.

We invite you to watch the advertisement.

¹Treatment of pain requiring stronger analgesic action than ibuprofen or paracetamol used separately.

APAP intense: ibuprofen 200 mg and paracetamol 500 mg, coated tablets. Indications for use: the medicinal product is used for the temporary relief of mild to moderate pain associated with migraine, headache, back pain, menstrual pain, toothache, rheumatic and muscular pain, pain associated with mild forms of arthritis, cold and flu, sore throat, or fever. The medicinal product is particularly suitable for the treatment of pain requiring stronger analgesic action than ibuprofen or paracetamol used separately. The APAP intense medicinal product is intended for adults aged 18 and over.

Contraindications: in patients with known hypersensitivity to the active substances or any excipients; in patients with a history of hypersensitivity reactions (e.g., bronchospasm, angioedema, asthma, rhinitis, or urticaria) associated with the intake of acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs); in patients with active or a history of recurrent peptic ulcer disease of the stomach and/or duodenum, and/or bleeding from the stomach or duodenum (at least two separate confirmed cases of ulceration or bleeding); in patients with ulceration, perforation, or bleeding from the gastrointestinal tract, active or in history, including cases associated with the intake of NSAIDs; in patients with coagulation disorders; in patients with severe liver failure, severe renal failure, or severe heart failure (NYHA class IV); when used concurrently with other drugs from the NSAID group, including selective cyclooxygenase-2 (COX-2) inhibitors and acetylsalicylic acid in doses greater than 75 mg per day – increased risk of adverse effects; when concomitantly using other medicinal products containing paracetamol – increased risk of severe adverse effects; in the last trimester of pregnancy concerning the risk of premature closure of the fetal ductus arteriosus and the occurrence of pulmonary hypertension.

Entity responsible: US Pharmacia, Sp. z o.o. ul. Ziębicka 40 50-507 Wrocław

Before use, please read the leaflet, which contains indications, contraindications, information about adverse effects and dosage, and information regarding the use of the medicinal product, or consult a doctor or pharmacist, as any improperly used medicine can endanger your life or health.